<DOC>
	<DOCNO>NCT02576652</DOCNO>
	<brief_summary>Bone Histomorphometry Proximal Femur Denosumab-treated Subjects Undergoing Total Hip Replacement</brief_summary>
	<brief_title>Bone Histomorphometry Subjects Undergoing Total Hip Replacement</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Demeclocycline</mesh_term>
	<criteria>Subject provide informed consent/assent prior initiation studyspecific activities/procedures Ambulatory postmenopausal woman men osteoporosis Scheduled undergo elective THR due osteoarthritis hip Received least 2 dos denosumab 60 mg subcutaneously 18 month Last dose denosumab within 6 month schedule THR Received treatment osteoporosis denosumab one year prior THR Subjects current diagnosis follow condition exclude Current , uncontrolled hypo hyperthyroidism ( subject control hypo hyperthyroidism may eligible , provide stable therapy least 3 month [ per subject report ] ) Current , hypo hyperparathyroidism Osteomalacia Paget 's disease bone Other bone disease affect bone metabolism ( eg , osteopetrosis , osteogenesis imperfecta ) Severe chronic kidney disease ( CKD ) , define CKD stage 4 great Malignancy within last 5 year ( except cervical carcinoma situ basal cell carcinoma ) Selfreported alcohol drug abuse within previous 12 month Currently receive treatment another investigational device drug study , less 30 day since end treatment another investigational device drug study ( ) Other investigational procedure participate study exclude Subject know sensitivity product administer ( eg , tetracycline , demeclocycline ) study Subject likely available complete protocolrequired study visit procedure , and/or comply require study procedure best subject investigator 's knowledge History evidence clinically significant disorder , condition disease ( exception outline ) , opinion investigator Amgen physician , consult , would pose risk subject safety interfere study evaluation , procedure completion</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>bone biopsy</keyword>
	<keyword>tetracycline</keyword>
	<keyword>demeclocycline</keyword>
	<keyword>total hip replacement</keyword>
</DOC>